Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer
Veronica Ghini, Letizia Laera, Beatrice Fantechi, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3574-3574
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 39
The heightened importance of the microbiome in cancer immunotherapy
C Villemin, Anne Six, Bridget A. Neville, et al.
Trends in Immunology (2022) Vol. 44, Iss. 1, pp. 44-59
Open Access | Times Cited: 49
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review
Suleiman Zakari, Nguedia K. Niels, Grace V. Olagunju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
Endoplasmic Reticulum Stress in Renal Cell Carcinoma
Marta Correia de Sousa, Etienne Delangre, Miranda Türkal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4914-4914
Open Access | Times Cited: 15
Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma
M CHU, Zhi Lei Zhang, Zhi Qiang Wang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41375-e41375
Open Access
Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
Xiaoxiao Du, Haoyuan Cao, Yujie Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Metabolomic Profiling in Lung Cancer: A Systematic Review
Daniela Madama, R. Martins, Ana Salomé Pires, et al.
Metabolites (2021) Vol. 11, Iss. 9, pp. 630-630
Open Access | Times Cited: 28
Systematic Review of NMR-Based Metabolomics Practices in Human Disease Research
Katherine Huang, Natalie Thomas, Paul R. Gooley, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 963-963
Open Access | Times Cited: 20
Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer
Jiayi Gao, Ping Zhang, Xin Nie, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109946-109946
Open Access | Times Cited: 4
Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches
Rudradeep Hazra, Soumyadeep Chattopadhyay, Arijit Mallick, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 4
Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy
Gopal P. Pathak, Rashmi R. Shah, Tony Reiman, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1340-1340
Open Access
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
Jian Deng, ShengYuan Tu, Lin Li, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis
Dang-Khoa Vo, Kieu The Loan Trinh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13190-13190
Open Access | Times Cited: 3
Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy
Chen Yan, Dan Wu, Lingling Gan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma
Dorin Novacescu, Bogdan Feciche, Alin Adrian Cumpănaş, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2926-2926
Open Access | Times Cited: 13
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies
Ryan C. Augustin, Wesley L. Cai, Jason J. Luke, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1724-1732
Closed Access | Times Cited: 2
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma
Jing Zhang, Qian Zhao, Hongwei Huang, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
Jing Xiao, Xiangcheng Qin, Hao Liu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC–MS metabolomics approach coupled with multivariate analysis
Manal E. Alosaimi, Badriyah S. Alotaibi, Maram H. Abduljabbar, et al.
Journal of Chromatography B (2024) Vol. 1240, pp. 124144-124144
Closed Access | Times Cited: 2
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma
Alvira Ajadee, Sabkat Mahmud, Md Bayazid Hossain, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310843-e0310843
Open Access | Times Cited: 2
Machine learning for prediction of immunotherapy efficacy in non-small cell lung cancer from simple clinical and biological data
Sébastien Benzekry, M. Grangeon, Mélanie Karlsen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
The Comprehensive “Omics” Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy
Sang Jun Yoon, Chae Bin Lee, Soon Uk Chae, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6932-6932
Open Access | Times Cited: 16
The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma
Omid Anbiyaee, Arash Moalemnia, Farhoodeh Ghaedrahmati, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma
Jiali Qin, Yang Yang, Wei Du, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
Karla Fabiola Corral‐Jara, Gonçalo Rosas da Silva, Nora A. Fierro, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top